Compounds > deamino-arginine-vasopressin

deamino-arginine-vasopressin and Turner-Syndrome

deamino-arginine-vasopressin has been researched along with Turner-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for deamino-arginine-vasopressin and Turner-Syndrome

Article	Year
A case report of severe panhypopituitarism in a newborn delivered by a women with Turner syndrome. Neuro endocrinology letters, 2015, Volume: 36, Issue:8 Turner syndrome (TS) is a congenital disease caused by absence or structural abnormalities of sex chromosomes resulting in gonadal dysgenesis. Spontaneous pregnancies occur in 2-8% of patients, especially with mosaic kariotypes, however they are associated with increased risk of poor outcome both for mother and fetus. We report a 4-day-old male infant delivered by women with mosaic TS who was admitted to the pediatric intensive care unit and presented with severe panhypopituitarism as the early manifestation of pituitary stalk interruption syndrome (PSIS). To the best of our knowledge this is the first report of severe panhypopituitarism in a newborn borne by women with TS. Topics: Antidiuretic Agents; Deamino Arginine Vasopressin; Female; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Infant, Newborn; Magnetic Resonance Imaging; Male; Pituitary Gland, Anterior; Pregnancy; Pregnancy Complications; Recombinant Proteins; Septum Pellucidum; Severity of Illness Index; Thyroxine; Turner Syndrome	2015

Article

Year

A case report of severe panhypopituitarism in a newborn delivered by a women with Turner syndrome.

Neuro endocrinology letters, 2015, Volume: 36, Issue:8

Turner syndrome (TS) is a congenital disease caused by absence or structural abnormalities of sex chromosomes resulting in gonadal dysgenesis. Spontaneous pregnancies occur in 2-8% of patients, especially with mosaic kariotypes, however they are associated with increased risk of poor outcome both for mother and fetus. We report a 4-day-old male infant delivered by women with mosaic TS who was admitted to the pediatric intensive care unit and presented with severe panhypopituitarism as the early manifestation of pituitary stalk interruption syndrome (PSIS). To the best of our knowledge this is the first report of severe panhypopituitarism in a newborn borne by women with TS.

Topics: Antidiuretic Agents; Deamino Arginine Vasopressin; Female; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Infant, Newborn; Magnetic Resonance Imaging; Male; Pituitary Gland, Anterior; Pregnancy; Pregnancy Complications; Recombinant Proteins; Septum Pellucidum; Severity of Illness Index; Thyroxine; Turner Syndrome

2015